Published in Br J Pharmacol on May 01, 1974
An analysis of the depressor responses to histamine in the cat and dog: involvement of both H1- and H2-receptors. Br J Pharmacol (1975) 2.91
Histamine receptors in peripheral vascular beds in the cat. Br J Pharmacol (1975) 1.46
The effects of histamine and some histamine-like agonists on blood pressure in the cat. Br J Pharmacol (1975) 1.40
Proceedings: Functional hyperaemia in soleus muscle of the cat. J Physiol (1975) 0.81
Proceedings: The effect of histamine on tissue blood flow in the cat. Br J Pharmacol (1975) 0.78
An analysis of the depressor responses to histamine in the cat and dog: involvement of both H1- and H2-receptors. 1975. Br J Pharmacol (1997) 0.75
An analysis of the depressor responses to histamine in the cat and dog: involvement of both H1- and H2-receptors. 1975. Br J Pharmacol (2010) 0.75
Definition and antagonism of histamine H 2 -receptors. Nature (1972) 18.58
Receptors mediating some actions of histamine. Br J Pharmacol Chemother (1966) 6.93
Metiamide--an orally active histamine H2-receptor antagonist. Agents Actions (1973) 6.82
Metiamide--an orally active histamine H2-receptor antagonist. Agents Actions (1973) 6.82
Dimaprit -(S-[3-(N,N-dimethylamino)prophyl]isothiourea) - a highly specific histamine H2 -receptor agonist. Part 1. Pharmacology. Agents Actions (1977) 3.33
Chemical differentiation of histamine H1- and H2-receptor agonists. J Med Chem (1975) 3.20
Peripheral beta-adrenergic receptors concerned with tremor. Clin Sci (1967) 2.97
Impromidine (SK&F 92676) is a very potent and specific agonist for histamine H2 receptors. Nature (1978) 2.91
An analysis of the depressor responses to histamine in the cat and dog: involvement of both H1- and H2-receptors. Br J Pharmacol (1975) 2.91
A quantitative study of metiamide, a histamine H2-antagonist, on the isolated whole rat stomach. J Physiol (1976) 2.56
Radiofrequency ablation of porcine liver in vivo: effects of blood flow and treatment time on lesion size. Ann Surg (1998) 2.19
Neural correlates of lexical access during visual word recognition. J Cogn Neurosci (2003) 1.81
Histamine receptors in the cardiovascular. Gen Pharmacol (1977) 1.80
Effect of adrenergic beta-blockade on parkinsonian tremor. Lancet (1965) 1.75
Letter: Quality evaluation in histopathology. Br Med J (1975) 1.54
The pharmacology of cimetidine, a new histamine H2-receptor antagonist. Br J Pharmacol (1975) 1.51
Effect of beta-adrenergic blockade on finger tremor and Achilles reflex time in anxious and thyrotoxic patients. Acta Endocrinol (Copenh) (1968) 1.48
The effect of metiamide on acid secretion stimulated by gastrin, acetylcholine and dibutyryl cyclic adenosine 3',5'-monophosphate in the isolated whole stomach of the rat. Br J Pharmacol (1976) 1.48
Histamine receptors in peripheral vascular beds in the cat. Br J Pharmacol (1975) 1.46
Pharmacological studies with SK&F 93944 (temelastine), a novel histamine H1-receptor antagonist with negligible ability to penetrate the central nervous system. Br J Pharmacol (1986) 1.43
Flat adenomas of the colon. Hum Pathol (1991) 1.43
The effects of histamine and some histamine-like agonists on blood pressure in the cat. Br J Pharmacol (1975) 1.40
A novel Alcian yellow-toluidine blue (Leung) stain for Helicobacter species: comparison with standard stains, a cost-effectiveness analysis, and supplemental utilities. Mod Pathol (1998) 1.37
Characterization and development of cimetidine as a histamine H2-receptor antagonist. Gastroenterology (1978) 1.35
Radiofrequency ablation followed by resection of malignant liver tumors. Am J Surg (1999) 1.30
The effect of reserpine on the pressor responses to angiotensin in the conscious cat. Br J Pharmacol (1970) 1.28
An association between primary biliary cirrhosis and jejunal villous atrophy resembling celiac disease. Dig Dis Sci (1979) 1.27
Proceedings: Vascular histamine receptors in the cat. Br J Pharmacol (1974) 1.17
Effect of dihydroergotamine (DHG) on the capacitance, resistance and precapillary sphincter vessels of denervated cat skeletal muscle. Br J Pharmacol (1971) 1.17
Differentiation of the roles of histamine H1- and H2-receptors in the mediation of the effects of histamine in the isolated working heart of the guinea-pig. Br J Pharmacol (1979) 1.17
Fructose prevents hypoxic cell death in liver. Am J Physiol (1987) 1.15
The effect of an inhibitor of matrix metalloproteinases on colonic inflammation in a trinitrobenzenesulphonic acid rat model of inflammatory bowel disease. Aliment Pharmacol Ther (1999) 1.15
Case report: multiple hepatic and pulmonary haemangioblastomas--a new manifestation of von Hippel-Lindau disease. Clin Radiol (1992) 1.13
Evidence for both histamine H1- and H2-receptors in the gastric vasculature of the cat. Br J Pharmacol (1980) 1.13
Mesohepatectomy. Am J Surg (2000) 1.13
Carcinoma of the stomach in young persons. Cancer (1985) 1.12
Cyanoguanidine-thiourea equivalence in the development of the histamine H2-receptor antagonist, cimetidine. J Med Chem (1977) 1.10
Malignant carcinoid tumor complicating chronic ulcerative colitis. Am J Clin Pathol (1981) 1.10
Pharmacological studies with SK&F 94120, a novel positive inotropic agent with vasodilator activity. J Pharm Pharmacol (1986) 1.09
The cardiovascular response to dimaprit, a selective histamine H2-receptor agonist. Br J Pharmacol (1977) 1.08
Evaluation of the role of Histamine H1- and H2-receptors in cutaneous inflammation in the guinea-pig produced by histamine and mast cell degranulation. Br J Pharmacol (1980) 1.07
The pharmacology of burimamide and metiamide, two histamine H2-receptor antagonists. Fed Proc (1976) 1.07
Clear-cell epithelial neoplasms of the large intestine. Arch Pathol Lab Med (1988) 1.06
Effects of histamine on human isolated heart muscle: comparison with effects of noradrenaline. J Pharm Pharmacol (1980) 1.06
Cardiovascular studies with impromidine (SK&F 92676), a new very potent and specific histamine H2-receptor agonist. J Pharm Pharmacol (1979) 1.05
An isolated guinea-pig working heart: preliminary studies with histamine and noradrenaline [proceedings]. Br J Pharmacol (1977) 1.05
Normal histology of the stomach. Am J Surg Pathol (1986) 1.05
Preclinical pharmacology of ropinirole (SK&F 101468-A) a novel dopamine D2 agonist. Pharmacol Biochem Behav (1991) 1.05
Analysis of the cost-effectiveness of PACS. AJR Am J Roentgenol (1991) 1.03
Objective measurement of parkinsonian tremor. Lancet (1965) 1.02
Hepatic hemangioblastoma. An unusual presentation in a patient with von Hippel-Lindau disease. Am J Surg Pathol (1991) 1.01
An investigation into the effect and mechanisms of action of nicotine in inflammatory bowel disease. Inflamm Res (2000) 1.00
The histochemical assessment of sulphated and non-sulphated sialomucin in intestinal epithelium. Histopathology (1985) 1.00
Studies on gastric acid secretion using an isolated whole mammalian stomach in vitro. J Physiol (1975) 1.00
Metronomic gemcitabine suppresses tumour growth, improves perfusion, and reduces hypoxia in human pancreatic ductal adenocarcinoma. Br J Cancer (2010) 1.00
Hypotensive and vasodilator actions of SK&F 24260, a new dihydropyridine derivative. Br J Pharmacol (1974) 0.99
Investigation of the role of histamine H1-receptors in the control of gastric acid secretion in the rat. J Pharm Pharmacol (1978) 0.99
Multiple microcarcinoids arising in chronic ulcerative colitis. Am J Clin Pathol (1992) 0.99
Massive bleeding from multiple gastric ulcerations in a patient with lymphocytic gastritis and celiac sprue. J Clin Gastroenterol (1997) 0.98
Mechanisms underlying emotional variation in parkinsonian tremor. Neurology (1967) 0.98
Hemodynamic profile of a new antihypertensive agent D,L-3-[2-(3-t-butylamino-2-hydroxypropoxy)phenyl]-6-hydrazinopyridazine (SK&F 92657). J Cardiovasc Pharmacol (1981) 0.98
Cardiovascular studies with SK&F 93319, an antagonist of histamine at both H1- and H2-receptors. Br J Pharmacol (1984) 0.98
Pharmacology and toxicology of metiamide, a histamine H2-receptor antagonist. S Afr Med J (1974) 0.97
Inotropic and electrophysiological effects of histamine on human ventricular heart muscle. J Physiol (1982) 0.97
Lymphocytic gastritis and giant gastric folds associated with gastrointestinal protein loss. Mod Pathol (1991) 0.96
Potentiation by angiotensin of responses to endogenously released noradrenaline in the pithed rat. Arch Int Pharmacodyn Ther (1969) 0.96
DNA synthesis in the preimplantation mouse embryo. J Embryol Exp Morphol (1972) 0.96
Reduction by cimetidine of acute gastric hemorrhage caused by reinfusion of blood after exposure to exogenous acid during gastric ischemia in rats. Gastroenterology (1979) 0.96
Dimaprit, (S-[3-(N,N-dimethylamino)propyl]isothiourea). A highly specific histamine H2-receptor agonist. Part 2. Structure-activity considerations. Agents Actions (1977) 0.96
3-Aminopropylphosphinic acid--a potent, selective GABAB receptor agonist in the guinea-pig ileum and rat anococcygeus muscle. Br J Pharmacol (1989) 0.95
An adrenergic neuron blocking action of propranolol in isolated tissues. J Pharm Pharmacol (1968) 0.95
Separation of rat muscle aminopeptidases. Biochem J (1976) 0.94
Investigation of the role of extracellular calcium in the control of acid secretion in the isolated whole stomach of the rat. Br J Pharmacol (1979) 0.94
Schwannoma of the pancreas: a report of two cases and a review of the literature. Mod Pathol (1998) 0.93
Tissue blood flow and distribution of cardiac output in cats: changes caused by intravenous infusions of histamine and histamine receptor agonists. Br J Pharmacol (1977) 0.93
Characterization of the antinociceptive properties of cimetidine and a structural analog. J Pharmacol Exp Ther (1996) 0.93
Serum creatine kinase studies in the detection of carriers of Duchenne dystrophy. J Neurol Neurosurg Psychiatry (1971) 0.93
The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis. Br J Pharmacol (2010) 0.93
The effects of adenosine triphosphate and related purines on arterial resistance vessels in vitro and in vivo. Eur J Pharmacol (1989) 0.92
BY 1023/SK&F 96022 INN pantoprazole, a novel gastric proton pump inhibitor, potently inhibits acid secretion but lacks relevant cytochrome P450 interactions. J Pharmacol Exp Ther (1990) 0.92
The cardiovascular effects of histamine in laboratory animals. Agents Actions (1974) 0.92
Clonidine-induced hypotension: further evidence for a central interaction with histamine H2 receptor antagonists in the rat. Neuropharmacology (1978) 0.92
The effect of atropine on acid secretion stimulated by acetylcholine, histamine and gastrin in the isolated whole stomach of the rat. Br J Pharmacol (1977) 0.91
Effects of histamine on the circulatory system. Klin Wochenschr (1982) 0.91
Studies on cutaneous vascular permeability in the rat: increases caused by histamine and histamine-like agents. Agents Actions (1984) 0.91
Topical and intravenous administration of trefoil factors protect the gastric mucosa from ethanol-induced injury in the rat. Aliment Pharmacol Ther (2000) 0.90
A simple technique to simultaneously assess activity at histamine H1- and H2-receptors in vivo. J Pharmacol Methods (1985) 0.90
Histamine release from human right atrium. Br J Pharmacol (1981) 0.89
The pressor activity of burimamide: a relationship between chemical constitution and pressor activity of burimamide and related histamine H2-receptor antagonists. Agents Actions (1977) 0.89
Modulation of the release of endogenous adenosine by cannabinoids in the myenteric plexus-longitudinal muscle preparation of the guinea-pig ileum. Br J Pharmacol (2002) 0.88
Reversible inhibitors of the gastric (H+/K+)-ATPase. 2. 1-Arylpyrrolo[3,2-c]quinolines: effect of the 4-substituent. J Med Chem (1992) 0.88
Interaction between histamine H2-receptor antagonists and the hypotensive effects of clonidine in rats [proceedings]. Br J Pharmacol (1977) 0.88
Celiac disease in a patient with morbid obesity. Arch Intern Med (1980) 0.88
Inverted Meckel's diverticulum: an entity simulating an ileal polyp. Am J Gastroenterol (1998) 0.88
Coexisting carcinoid tumors in familial adenomatous polyposis-associated upper intestinal adenomas. Am J Gastroenterol (1999) 0.88
Pancreatic spasmolytic polypeptide protects the gastric mucosa but does not inhibit acid secretion or motility. Am J Physiol (1997) 0.87
Collecting duct carcinoma of the kidney: a case report and review of the literature. J Urol (1992) 0.87